Presently, the correlation between chemoresistance and mitochondrial dynamic proteins has been shown that OPA1 loss-induced mitochondrial fragmentation tends to cause an increase in resistance to drug treatments in cancers [47]. This evidence concerns the gene OPA1 and cancer.